Therapeutic Effectiveness of Neuraminidase-Treated Allogeneic Myeloblasts as Immunogen in Acute Myelocytic Leukemia-Reference-Cited by-同舟云学术

Therapeutic Effectiveness of Neuraminidase-Treated Allogeneic Myeloblasts as Immunogen in Acute Myelocytic Leukemia

Published:1982 Issue: Volume: Page:42-55
ISSN:0080-0015
Container-title:Recent Results in Cancer Research
language:
Short-container-title:

Author:

Bekesi J. G.,Holland J. F.

Publisher

Springer Berlin Heidelberg

Link

http://link.springer.com/content/pdf/10.1007/978-3-642-81685-7_8.pdf

Reference22 articles.

1. Bagshawe KD, Currie GA (1968) Immunogenicity of L1210 murine leukemia cells after treatment with neuraminidase. Nature 218:1254

2. Bekesi JG, St Arneault G, Holland JF (1971) Increase of leukemia L1210 immunogenicity by Vibrio cholerae neuraminidase treatment. Cancer Res 31:2130

3. Bekesi JG, St Arneault G, Walter L, Holland JG (1972) Immunogenicity of leukemia L1210 cells after neuraminidase treatment. J Natl Cancer Inst 41:107

4. Bekesi JG, Roboz JP, Walter L, Holland JF (1974) Stimulation of specific immunity against cancer by neuraminidase-treated tumor cells. Behring Inst Mitt 55:309

5. Bekesi JG, Holland JF, Fleminger R, et al. (1977) Immunotherapeutic efficacy of neuraminidase-treated allogeneic myeloblasts in patients with acute myelocytic leukemia. In: Chirigos MA (ed) Control of neoplasia by modulation of the immune system. Raven Press, New York, p 573

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A phase-I clinical trial of active immunotherapy for acute leukemia using inactivated autologous leukemia cells mixed with IL-2, GM-CSF, and IL-6;Leukemia Research;2005-01

2. Enzyme Applications, Therapeutic;Kirk-Othmer Encyclopedia of Chemical Technology;2000-12-04

3. Immunotherapy;Cancer Management in Man;1989

4. Immunology and Immunotherapy of Human Malignant Melanoma;Dermatologic Clinics;1985-04